Profiel
Nathalie Riebel, formerly a Director of Clinical Operations at ImClone LLC, Director of Global Quality & Inspection at Eli Lilly & Co., Director of Clinical Operations at ICON plc, Director of Clinical Operations at GSK Plc, and currently serving as the Senior Vice President of Clinical Operations at PDS Biotechnology Corp.
Eerdere bekende functies van Nathalie Riebel
Bedrijven | Functie | Einde |
---|---|---|
PDS BIOTECHNOLOGY CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-12-2023 |
ICON PUBLIC LIMITED COMPANY | Hoofd Techniek/Wetenschap/O&O | 01-03-2011 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Hoofd Techniek/Wetenschap/O&O | - |
GSK PLC | Hoofd Techniek/Wetenschap/O&O | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
PDS BIOTECHNOLOGY CORPORATION | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
GSK PLC | Health Technology |
ICON PUBLIC LIMITED COMPANY | Commercial Services |
Bedrijven in privébezit | 1 |
---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |